All News
Want to Go Far, Go Together (4.21.2023)
This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.
Read Article
Antiphospholipid Antibodies With Incident Cardiovascular Events
Are antiphospholipid antibodies (aPL) associated with atherosclerotic cardiovascular (ASCVD) event risk? A cohort study has shown that aPL Abs are found in a substantial proportion of adults with ASCVD events and finding both positive aCL IgA and aβ2GPI IgA Abs independently predicted futur
Read Article
Our old friend, hydroxychloroquine
After an action packed weekend, RheumNow Live 2023 concluded on Sunday with a half-day session on systemic lupus erythematous and ankylosing spondylitis discussing many new medications that are revolutionizing rheumatology. Dr. Laurent Arnaud, a professor at Strasbourg University in France, however, took the time to review one of our oldest therapies: hydroxychloroquine.
Read Article
NIH sponsored nationwide survey assessed 1,462 SLE pts (9% men; 81% women). Male SLE pts had more MI & difficultly w/ medical forms than F. Female SLE had more fatiguer and higher educational levels. Both had barriers to health care access (40-47%) https://t.co/1u7bsyn3fD https://t.co/RTXyiuP972
Links:
Dr. John Cush RheumNow ( View Tweet)
Join us 4/25 as we conclude our Women in Rheumatology campaign by focusing on what's next. Our panelists will recap the challenges addressed this month and discuss a strategy to suppot women in rheumatology.
https://t.co/DP4S2hf5Tz
@uptoTate @KDAO2011 @gwenesta_melton https://t.co/rcglaZxqoF
Links:
Dr. John Cush RheumNow ( View Tweet)
TNR: Private Practice & Academia
In this session, our panelists addressed the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?".
https://t.co/yMJ5mCtSXX
@KDAO2011 https://t.co/eeFYkLYsAh
Links:
Dr. John Cush RheumNow ( View Tweet)
NIH sponsored nationwide survey assessed 1,462 SLE pts (9% men; 81% women). Male SLE pts had more MI & difficultly w/ medical forms than F. Female SLE had more fatiguer and higher educational levels. Both had barriers to health care access (40-47%) https://t.co/A0Zv5IvXnh https://t.co/BFMspCs6yE
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Megan E.B. Clowse discusses the differences in pregnancy planning for men and women with rheumatic disesase.
https://t.co/KLyrGbYzJc https://t.co/E2Ep6BqvBN
Links:
Dr. John Cush RheumNow ( View Tweet)
Join us April 18 for: Private Practice & Academia
In this session, our panelists will address the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?".
https://t.co/BrWG57mRRG https://t.co/A0pzEvJ3cu
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Megan Clowse discusses the differences in pregnancy planning for men and women with rheumatic disease, with particular focus on medication use. Watch now.
https://t.co/Ine8CdbZR4 https://t.co/7UnanlnQcC
Links:
Dr. John Cush RheumNow ( View Tweet)
Antiphospholipid Antibodies With Incident Cardiovascular Events
Are antiphospholipid antibodies (aPL) associated with atherosclerotic cardiovascular (ASCVD) event risk?
https://t.co/XQk17P6D2f https://t.co/y5exrsicW8
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumThoughts: Changing the Conversation with Patients: Lupus
Join the discussion! RheumThoughts are opinion pieces from healthcare professionals.
https://t.co/NcJcCZVlbE
@drbags71 https://t.co/VfAqUkqLak
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumThoughts: Changing the Conversation with Patients: Lupus
https://t.co/rFM2211Toq https://t.co/I9yWGMCH9B
Links:
Dr. John Cush RheumNow ( View Tweet)
The Origin Story: Women in Rheumatology--The XX Factor
When asked to run a campaign to highlight the achievements and challenges of women in rheumatology, I was ecstatic because we have has so many heroines who have contributed to our field.
https://t.co/ucQIPjQ8Tu https://t.co/g81EtAwYYL
Links:
Dr. John Cush RheumNow ( View Tweet)
Drs. Tate and Dao will be leading discussions on Women in Rheumatology, the XX Factor.
Sign up to attend our Tuesday Night Rheumatology series.
@uptoTate @KDAO2011
https://t.co/ciEAY1SJdg https://t.co/dlCfXItAxN
Links:
Dr. John Cush RheumNow ( View Tweet)
Tomorrow! Join us for Tuesday Night Rheumatology.
Our panelists will discuss the challenges they have faced trying to manage a career and family life, as well as provide advice and strategies for managing competing priorities and obligations.
https://t.co/OlP0pupkMV https://t.co/pZQMASafcG
Links:
Dr. John Cush RheumNow ( View Tweet)
Abbvie has completed a phase II upadacitinib vs combo elsubrutinib/upadacitinib ( ABBV-599) in active #SLE - M19-130 (SLEek) Phase 2 trial met the primary endpoint SRI-4 response and pred dose<=10 mg qd. No new safety signals - Phase III trial planned https://t.co/6CwS2AVamH https://t.co/b4wQ6IoiOz
Links:
Dr. John Cush RheumNow ( View Tweet)
Autoimmune-Rheum Dz (AIRD) flares occur in 10% w/ COVID vaccination, esp in pts w/ comorbidities, autoimmune morbidities & mental health disorders & Moderna vaccine. 3453 AIRD pts who recv Vax 9.5-11.3% had clinical flares (Arthritis 62% & fatigue 59%) https://t.co/RCtQnA9vc9 https://t.co/G5cXukkpUB
Links:
Dr. John Cush RheumNow ( View Tweet)
LRA announces the 2023 recipients of the Lupus Innovation Award during #NationalKidneyMonth as three of this year’s seven award recipients are studying issues that come with this too-common complication.
🧵1of2 https://t.co/VZL9qJu9kF
Lupus Research LupusResearch ( View Tweet)
Have a Rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
https://t.co/MMHvtkbz9l https://t.co/3aNijNJWkW
Links:
Dr. John Cush RheumNow ( View Tweet)
